Texas A&M Football

A chocolate milk roundtable with Caroline Fenton & T-Bob Hebert

The LSU Tigers took the podium on Monday at SECMD24 in Dallas, so TexAgs' co-owner and executive editor Billy Liucci caught up with Caroline Fenton of Yahoo Sports and T-Bob Hebert of ESPN Baton Rouge to get the low down on the Bayou Bengals and much, much more.
By Billy Liucci
July 15, 2024
6.1k Views
Discuss
Story Poster
Photo by Luke Evangelist, TexAgs

The LSU Tigers took the podium on Monday at SECMD24 in Dallas, so TexAgs' co-owner and executive editor Billy Liucci caught up with Caroline Fenton of Yahoo Sports and T-Bob Hebert of ESPN Baton Rouge to get the low down on the Bayou Bengals and much, much more.

To watch this video, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Collin Klein Mike Elko Michael Earley Offensive Line Bo Pelini Will Muschamp Mark Stoops Steve Spurrier Dan Mullen Nick Saban Lane Kiffin Jimbo Fisher
Show All
SEC Media Days Steve Sarkisian Jim Schlossnagle Transfer Portal T-Bob Hebert Caroline Fenton Mike Denbrock Kevin O’Sullivan Graham Mertz Aaron Murray Kalen DeBoer Riley Leonard Garrett Nussmeier SEC Media Days 2024 SEC Media Days Texas A&M vs. Notre Dame Texas A&M at Florida Texas A&M vs. Missouri SEC Media Days 2024 Johnny Manziel Moose Muhammad III Conner Weigman Jace LaViolette Football Baseball Texas A&M Oklahoma Texas Washington Missouri LSU Notre Dame Florida Alabama Ole Miss Kentucky 2024
SPONSORED BY
Aggieland Chevrolet
More Football
See All →
Ask Liucci: Analyzing the matchups in No. 9 A&M vs. Auburn and more
By Billy Liucci
Looch & Bock: Getting set for Aggies-Auburn, new SEC schedules & more
By Billy Liucci
Tale of the Tape: No. 9 Texas A&M vs. Auburn
By TexAgs
Around CFB: Time for Aggies to prove they can overcome prosperity
By Olin Buchanan
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.